Test will serve as a companion diagnostic for Bayer’s HYRNUO™ (sevabertinib) to identify patients with NSCLC eligible for HER2-targeted therapy CARLSBAD, Calif. — Thermo Fisher Scientific, the world leader in serving science, has received approval from the U.S. Food and Drug Administration (FDA) for its Ion Torrent™ Oncomine™ Dx Target Test as a companion diagnostic […]
SOUTH SAN FRANCISCO, Calif. — Mission Bio, a leader in single-cell multi-omics solutions for precision medicine, today announced its Tapestri® Single-Cell Targeted DNA + RNA Assay, the first commercial platform to measure genotypic and transcriptional readouts within the same cell. The assay empowers oncology and translational researchers to directly link mutations to their functional consequences, […]
New Multiplex qPCR Assay developed in collaboration with Coca-Cola Europacific Partners delivers faster, broader detection to help protect product quality and brand reputation Thermo Scientific™ SureTect™ Beverage Spoilage Multiplex qPCR Assay, part of the Thermo Scientific SureTect PCR System WALTHAM, Mass. — To support the quality of beverage products, Thermo Fisher Scientific today introduced the […]
Next-generation magnetic bead-based kit designed for fast and efficient nucleic acid purification from diverse sample types Manchester, UK: Primerdesign (part of the Novacyt Group), a company focused on the design, manufacture, validation and supply of real-time PCR kits and reagents, today announced the launch of its exsig® Mag RapidBead Pro Extraction kit. The next-generation magnetic bead-based […]
Shimadzu Corporation (head office: Nakagyo-ku, Kyoto; Representative Director, President & CEO Yasunori Yamamoto, hereinafter “Shimadzu”) announced today that it has entered into a strategic partnership agreement (hereinafter “Partnership Agreement”) with Japan Activation Capital, Inc. (Representative Director & CEO Hiroyuki Otsuka, hereinafter “JAC”) to achieve sustainable growth and increase corporate value at Shimadzu. Background to the […]
New method enables single cell discovery from archived tissue samples, expanding access to translational and clinical research SEATTLE — Parse Biosciences, the leading provider of scalable and accessible single cell sequencing solutions, today announced a breakthrough technology that unlocks the full potential of formalin-fixed, paraffin-embedded (FFPE) samples. By enabling whole transcriptome capture from archived tissues […]
New state-of-the-art facility in Philadelphia provides integrated lab and collaboration space along with tailored guidance to help move advanced therapies from early research to clinical readiness WALTHAM, Mass. — Thermo Fisher Scientific Inc., the world leader in serving science, today announced the grand opening of its East Coast flagship Advanced Therapies Collaboration Center (ATxCC) in […]
– Partnership focuses on “kitted” tests in ex-U.S. markets, enabling accelerated access through a decentralized model – – Deal potentially worth $200+ million increases Roche’s investment in Freenome with $75 million equity instrument and R&D support through innovative applications and technology collaboration – Brisbane, CA —Freenome, an early cancer detection company developing blood-based screening tests, today announced […]
IRVINE, Calif. — Zymo Research, a global leader in next-generation sequencing (NGS), has entered a strategic partnership with biomodal, an omics-based life sciences technology and analytics company. As part of biomodal’s certified provider network, Zymo Research’s NGS Services division is now authorized to deliver services using biomodal’s duet multiomics solutions, enabling researchers to access comprehensive genetic […]
BUILT Biotechnologies, Inc., an emerging leader in DNA Manufacturing-as-a-Service, today announced expanded commercial and manufacturing capabilities and the onboarding of more than 50 new customers with large-scale DNA construction needs for genome engineering and beyond. “Researchers advancing ambitious genome engineering programs rely on high-fidelity, large-scale DNA,” said George McArthur, PhD, CEO of BUILT. “Our unrivaled […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
